Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$2.93B |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$1.72B |
| 3 |
Microsoft
MSFT
|
+$1.23B |
| 4 |
Vanguard Short-Term Bond ETF
BSV
|
+$1.04B |
| 5 |
iShares Core MSCI EAFE ETF
IEFA
|
+$891M |
Top Sells
| 1 |
iShares Russell 2000 ETF
IWM
|
+$1.73B |
| 2 |
Apple
AAPL
|
+$1.64B |
| 3 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$1.55B |
| 4 |
ATVI
Activision Blizzard Inc.
ATVI
|
+$639M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$595M |
Sector Composition
| 1 | Technology | 20.41% |
| 2 | Financials | 10.04% |
| 3 | Consumer Discretionary | 9.06% |
| 4 | Healthcare | 8.84% |
| 5 | Industrials | 5.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1651
NOV
NOV
$4.83B
| $17.8M | ﹤0.01% |
879,960
+429,104
| +95% | +$8.7M |
|
1652
Sarepta Therapeutics
SRPT
$1.93B
| $17.8M | ﹤0.01% |
184,870
-558,022
| -75% | -$53.8M |
|
1653
Rocket Pharmaceuticals
RCKT
$340M
| $17.8M | ﹤0.01% |
594,665
+64,946
| +12% | +$1.95M |
|
1654
TD Synnex
SNX
$12.4B
| $17.8M | ﹤0.01% |
164,999
+64,024
| +63% | +$6.89M |
|
1655
Nomura Holdings
NMR
$22.1B
| $17.7M | ﹤0.01% |
3,933,656
+689,849
| +21% | +$3.11M |
|
|
KERNW
1656
DELISTED
Akerna Corp Warrant
KERNW
| $17.6M | ﹤0.01% |
58,680
| – | – |
|
1657
Viavi Solutions
VIAV
$2.76B
| $17.6M | ﹤0.01% |
1,751,842
-2,112,529
| -55% | -$21.3M |
|
|
RPT
1658
DELISTED
RPT Realty Common Shares of Beneficial Interest (MD)
RPT
| $17.6M | ﹤0.01% |
1,374,425
-136,013
| -9% | -$1.75M |
|
1659
Green Plains
GPRE
$675M
| $17.6M | ﹤0.01% |
698,968
+129,878
| +23% | +$3.28M |
|
1660
SiTime
SITM
$7.94B
| $17.6M | ﹤0.01% |
143,925
-30,666
| -18% | -$3.74M |
|
1661
Aramark
ARMK
$9.93B
| $17.5M | ﹤0.01% |
624,159
-5,695,766
| -90% | -$160M |
|
1662
ThredUp
TDUP
$1.31B
| $17.5M | ﹤0.01% |
7,791,292
| – | – |
|
1663
MSC Industrial Direct
MSM
$5.16B
| $17.5M | ﹤0.01% |
172,394
-20,032
| -10% | -$2.03M |
|
1664
Structure Therapeutics
GPCR
$1.34B
| $17.4M | ﹤0.01% |
427,735
+356,302
| +499% | +$14.5M |
|
|
GHIX
1665
DELISTED
Gores Holdings IX, Inc. Class A Common Stock
GHIX
| $17.4M | ﹤0.01% |
1,657,294
+1,000
| +0.1% | +$10.5K |
|
1666
Primoris Services
PRIM
$6.86B
| $17.4M | ﹤0.01% |
523,789
+288,651
| +123% | +$9.59M |
|
1667
Celldex Therapeutics
CLDX
$1.72B
| $17.4M | ﹤0.01% |
437,759
+25,925
| +6% | +$1.03M |
|
1668
Xenon Pharmaceuticals
XENE
$2.91B
| $17.3M | ﹤0.01% |
376,302
+120,934
| +47% | +$5.57M |
|
1669
Corcept Therapeutics
CORT
$8.4B
| $17.3M | ﹤0.01% |
532,760
+124,185
| +30% | +$4.03M |
|
1670
Payoneer
PAYO
$2.4B
| $17.3M | ﹤0.01% |
3,312,665
-282,755
| -8% | -$1.47M |
|
1671
Ciena
CIEN
$19.5B
| $17.2M | ﹤0.01% |
382,929
+1,967
| +0.5% | +$88.5K |
|
1672
iRhythm Technologies
IRTC
$5.65B
| $17.2M | ﹤0.01% |
160,728
-122,635
| -43% | -$13.1M |
|
1673
Urban Edge Properties
UE
$2.62B
| $17.2M | ﹤0.01% |
939,179
+157,792
| +20% | +$2.89M |
|
1674
Kymera Therapeutics
KYMR
$3.65B
| $17.2M | ﹤0.01% |
674,655
+469,947
| +230% | +$12M |
|
1675
Invesco BulletShares 2025 High Yield Corporate Bond ETF
BSJP
$703M
| $17.1M | ﹤0.01% |
+752,188
| New | +$17.1M |
|